FDA Approves Another Lower-Dose NSAIDFDA Approves Another Lower-Dose NSAID

The new product, indomethacin 20 mg and 40 mg, is the company's second lower-dose NSAID to get FDA approval in about 4 months FDA Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news